Encompass Health (EHC) Institutional Ownership
13F filers reported holding 64.9% of Encompass Health (EHC) shares as of Sep 30, 2026, across 508 filers.
- Held by 13F filers
- 64.9%
- Sep 30, 2026
- 13F filers
- 508
- quarter ended Sep 30, 2026
- 13F value
- $7.7B
- 63.7M shares
- Quarter's fund flow
- Mild accumulation
- 71 new · 41 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Christie Edward M III | director | Acquired · Grant / award | 221 | $126.63 | ↗ |
| Oct 19, 2026 | Reidy Christopher R | director | Acquired · Grant / award | 284 | $126.89 | ↗ |
| Oct 15, 2026 | CARMICHAEL GREG D | director | Acquired · Grant / award | 28 | — | ↗ |
| Oct 15, 2026 | Williams Terrance | director | Acquired · Grant / award | 28 | — | ↗ |
| Oct 15, 2026 | SCHLICHTING NANCY M | director | Acquired · Grant / award | 38 | — | ↗ |
| Oct 15, 2026 | HERMAN JOAN E | director | Acquired · Grant / award | 81 | — | ↗ |
| Oct 15, 2026 | Christie Edward M III | director | Acquired · Grant / award | 11 | — | ↗ |
| Oct 15, 2026 | Reidy Christopher R | director | Acquired · Grant / award | 20 | — | ↗ |
| Oct 15, 2026 | Hayes Cain A | director | Acquired · Grant / award | 4 | — | ↗ |
| Oct 15, 2026 | O'Connor Kevin J. | director | Acquired · Grant / award | 18 | — | ↗ |
| Oct 15, 2026 | KATZ LESLYE G | director | Acquired · Grant / award | 81 | — | ↗ |
| Aug 31, 2026 | Price Andrew L | Chief Accounting Officer | Disposed · Open-market sale | 5,211 | $120.93 | ↗ |
| Aug 31, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | Acquired · Option exercise | 4,858 | $35.06 | ↗ |
| Aug 31, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | Disposed · Open-market sale | 4,858 | $121.09 | ↗ |
| Aug 31, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | Disposed · Option exercise | 4,858Non-qualified Stock Option (Right to Buy) | — | ↗ |
| Aug 10, 2026 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Disposed · Open-market sale | 18,869 | $125.38 | ↗ |
| Aug 10, 2026 | Tarr Mark J | President & CEO | Disposed · Open-market sale | 171,569 | $125.46 | ↗ |
| Aug 10, 2026 | Tarr Mark J | President & CEO | Disposed · Open-market sale | 1,579 | $126.06 | ↗ |
| Aug 10, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | Disposed · Open-market sale | 8,906 | $125.95 | ↗ |
| Jul 16, 2026 | Reidy Christopher R | director | Acquired · Grant / award | 319 | $112.40 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Encompass Health do institutions hold?
13F filers reported holding 64.9% of Encompass Health's shares as of Sep 30, 2026, across 508 filers.
How many 13F filers hold Encompass Health?
Encompass Health was held by 508 13F filers as of Sep 30, 2026.
Not investment advice.

